Nizatidine

ATC Code A02BA04

Nizatidine

Definition

A competitive and reversible histamine H2-receptor antagonist with antacid activity. Nizatidine inhibits the histamine H2-receptors located on the basolateral membrane of the gastric parietal cell, thereby reducing basal and nocturnal gastric acid secretion, resulting in a reduction in gastric volume, acidity, and amount of gastric acid released in response to stimuli.

Also known as Axid, NIZATIDINE — per NCIT

Also identified as

Indications

Disease Relation Source
Duodenal ulcer may prevent MEDRT · Public domain (U.S. Government work)
Gastric ulcer may prevent MEDRT · Public domain (U.S. Government work)
Duodenal ulcer may treat MEDRT · Public domain (U.S. Government work)
Dyspepsia may treat MEDRT · Public domain (U.S. Government work)
Gastric ulcer may treat MEDRT · Public domain (U.S. Government work)
Gastroesophageal reflux disease may treat MEDRT · Public domain (U.S. Government work)
Helicobacter pylori infectious disease may treat MEDRT · Public domain (U.S. Government work)
Peptic esophagitis may treat MEDRT · Public domain (U.S. Government work)
Urticaria may treat MEDRT · Public domain (U.S. Government work)
Zollinger-Ellison syndrome may treat MEDRT · Public domain (U.S. Government work)

Organ Effects

Organ Side effect / interaction Source
Alimentary part of gastrointestinal system may treat a disease of this organ DERIVED · CC BY 4.0
Esophagus may treat a disease of this organ DERIVED · CC BY 4.0
Intestine may treat a disease of this organ DERIVED · CC BY 4.0
Skin of body may treat a disease of this organ DERIVED · CC BY 4.0
Small intestine may treat a disease of this organ DERIVED · CC BY 4.0
Stomach may treat a disease of this organ DERIVED · CC BY 4.0
Upper digestive tract may treat a disease of this organ DERIVED · CC BY 4.0

7 entries above are marked DERIVED: Atlas Médico inferred them by combining two sourced claims, and no source asserts these links directly. Treat them as a navigation aid, not as a clinical statement.